pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Bio-pharma Market Report 2017


Published On : May 2017

Category : Pharmaceutical

No. of Pages : 110 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Bio-pharma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Bio-pharma for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Bio-pharma market competition by top manufacturers/players, with Bio-pharma sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Bio-pharma for each application, including
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

In the recent times, the global market for Emea europe middle east and africa bio pharma market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa bio pharma market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa bio pharma market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa bio pharma market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa bio pharma market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa bio pharma market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa bio pharma market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa bio pharma market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa bio pharma market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa bio pharma market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa bio pharma market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa bio pharma market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa bio pharma market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Bio-pharma
Figure EMEA Bio-pharma Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Bio-pharma Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Recombinant Proteins Product Picture
Figure Granulocyte-Colony Stimulating Factor (G-CSF) Product Picture
Figure Interferons Product Picture
Figure Recombinant Human Insulin Product Picture
Figure Erythropoietin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Purified Proteins Product Picture
Figure Others Product Picture
Figure EMEA Bio-pharma Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Bio-pharma by Application in 2016
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurological Disorders Examples
Table Key Downstream Customer in Neurological Disorders
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Inflammatory and Infectious Diseases Examples
Table Key Downstream Customer in Inflammatory and Infectious Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Bio-pharma Market Size (Million USD) by Region (2012-2022)
Figure Europe Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Bio-pharma Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Bio-pharma Revenue (Million USD) Status and Forecast by Countries
Figure Africa Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Bio-pharma Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Bio-pharma Sales Volume and Growth Rate (2012-2022)
Figure EMEA Bio-pharma Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Bio-pharma Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Bio-pharma Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Bio-pharma Sales Share by Players (2012-2017)
Figure 2016 Bio-pharma Sales Share by Players
Figure 2017 Bio-pharma Sales Share by Players
Figure EMEA Bio-pharma Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Bio-pharma Revenue (Million USD) by Players (2012-2017)
Table EMEA Bio-pharma Revenue Share by Players (2012-2017)
Table 2016 EMEA Bio-pharma Revenue Share by Players
Table 2017 EMEA Bio-pharma Revenue Share by Players
Table EMEA Bio-pharma Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Bio-pharma Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Bio-pharma Sales Share by Type (2012-2017)
Figure Sales Market Share of Bio-pharma by Type (2012-2017)
Figure EMEA Bio-pharma Sales Market Share by Type (2012-2017)
Table EMEA Bio-pharma Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Bio-pharma Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bio-pharma by Type in 2016
Table EMEA Bio-pharma Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Bio-pharma Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Bio-pharma Sales Share by Application (2012-2017)
Figure Sales Market Share of Bio-pharma by Application (2012-2017)
Figure EMEA Bio-pharma Sales Market Share by Application in 2016
Table EMEA Bio-pharma Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Bio-pharma Sales Share by Region (2012-2017)
Figure Sales Market Share of Bio-pharma by Region (2012-2017)
Figure EMEA Bio-pharma Sales Market Share in 2016
Table EMEA Bio-pharma Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Bio-pharma Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Bio-pharma by Region (2012-2017)
Figure EMEA Bio-pharma Revenue Market Share Regions in 2016
Table EMEA Bio-pharma Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Bio-pharma Revenue and Growth Rate (2012-2017)
Table Europe Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table Europe Bio-pharma Market Share by Type (2012-2017)
Figure Europe Bio-pharma Market Share by Type in 2016
Table Europe Bio-pharma Sales (K Pcs) by Application (2012-2017)
Table Europe Bio-pharma Market Share by Application (2012-2017)
Figure Europe Bio-pharma Market Share by Application in 2016
Table Europe Bio-pharma Sales (K Pcs) by Countries (2012-2017)
Table Europe Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Sales Market Share by Countries in 2016
Table Europe Bio-pharma Revenue (Million USD) by Countries (2012-2017)
Table Europe Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Europe Bio-pharma Revenue Market Share by Countries in 2016
Figure Germany Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Bio-pharma Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table Middle East Bio-pharma Market Share by Type (2012-2017)
Figure Middle East Bio-pharma Market Share by Type (2012-2017)
Table Middle East Bio-pharma Sales (K Pcs) by Applications (2012-2017)
Table Middle East Bio-pharma Market Share by Applications (2012-2017)
Figure Middle East Bio-pharma Sales Market Share by Application in 2016
Table Middle East Bio-pharma Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Bio-pharma Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Bio-pharma Sales Volume Market Share by Countries in 2016
Table Middle East Bio-pharma Revenue (Million USD) by Countries (2012-2017)
Table Middle East Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Middle East Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Middle East Bio-pharma Revenue Market Share by Countries in 2016
Figure Saudi Arabia Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Bio-pharma Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Bio-pharma Sales (K Pcs) by Type (2012-2017)
Table Africa Bio-pharma Sales Market Share by Type (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Type (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Type in 2016
Table Africa Bio-pharma Sales (K Pcs) by Application (2012-2017)
Table Africa Bio-pharma Sales Market Share by Application (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Application (2012-2017)
Table Africa Bio-pharma Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Sales Market Share by Countries in 2016
Table Africa Bio-pharma Revenue (Million USD) by Countries (2012-2017)
Table Africa Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Revenue Market Share by Countries (2012-2017)
Figure Africa Bio-pharma Revenue Market Share by Countries in 2016
Figure South Africa Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Table Pfizer Bio-pharma Basic Information List
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Pfizer Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche AG Bio-pharma Basic Information List
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche AG Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Services Bio-pharma Basic Information List
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Services Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Sanofi, Amgen Bio-pharma Basic Information List
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi, Amgen Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Sanofi, Amgen Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table AbbVie Bio-pharma Basic Information List
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure AbbVie Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc Bio-pharma Basic Information List
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Merck & Co., Inc Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Biogen Idec Bio-pharma Basic Information List
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Idec Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogen Idec Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Biogen Idec Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Bio-pharma Basic Information List
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer AG Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Bio-pharma Basic Information List
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Basic Information List
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Sales Market Share in EMEA (2012-2017)
Figure Novartis AG GlaxoSmithKline Plc Bio-pharma Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company Bio-pharma Basic Information List
Table AstraZeneca PLC Bio-pharma Basic Information List
Table Abbott Laboratories Bio-pharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-pharma
Figure Manufacturing Process Analysis of Bio-pharma
Figure Bio-pharma Industrial Chain Analysis
Table Raw Materials Sources of Bio-pharma Major Manufacturers in 2016
Table Major Buyers of Bio-pharma
Table Distributors/Traders List
Figure EMEA Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Bio-pharma Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Bio-pharma Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Bio-pharma Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Bio-pharma Sales Market Share Forecast by Region (2017-2022)
Table EMEA Bio-pharma Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Bio-pharma Revenue Market Share Forecast by Region (2017-2022)
Table Europe Bio-pharma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Bio-pharma Sales Market Share Forecast by Countries (2017-2022)
Table Europe Bio-pharma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Bio-pharma Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Bio-pharma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Bio-pharma Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Bio-pharma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Bio-pharma Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Bio-pharma Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Bio-pharma Sales Market Share Forecast by Countries (2017-2022)
Table Africa Bio-pharma Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Bio-pharma Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Bio-pharma Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Bio-pharma Sales Market Share Forecast by Type (2017-2022)
Table EMEA Bio-pharma Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Bio-pharma Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top